BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6324812)

  • 21. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
    Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O
    Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
    Miller WC; Moore JB
    Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
    Ishii A
    Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of [3H]nitrendipine binding and KCl-induced calcium uptake in rat cortical synaptosomes.
    Wei JW; Chiang DH
    Gen Pharmacol; 1985; 16(3):211-6. PubMed ID: 3160632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dantrolene sodium on [3H]nitrendipine binding to rat cardiac plasma membranes.
    Pong SF; Demuth SM; White RL
    J Pharm Pharmacol; 1985 Nov; 37(11):830-2. PubMed ID: 2867170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.
    Thorgeirsson G; Rudolph SA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):657-63. PubMed ID: 6329206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of KB-2796, a new calcium antagonist, and other diphenylpiperazines on [3H]nitrendipine binding.
    Iwamoto T; Morita T; Kanazawa T; Ohtaka H; Ito K
    Jpn J Pharmacol; 1988 Oct; 48(2):241-7. PubMed ID: 2850381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
    Janis RA; Rampe D; Sarmiento JG; Triggle DJ
    Biochem Biophys Res Commun; 1984 May; 121(1):317-23. PubMed ID: 6203531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine.
    Erne P; Bürgisser E; Bühler FR; Dubach B; Kühnis H; Meier M; Rogg H
    Biochem Biophys Res Commun; 1984 Feb; 118(3):842-7. PubMed ID: 6322768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects.
    Reynolds IJ; Gould RJ; Snyder SH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):628-32. PubMed ID: 6502516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional distribution of [3H]nitrendipine binding in human brain.
    Hanada S; Tanaka C
    Neurosci Lett; 1985 Aug; 58(3):375-80. PubMed ID: 2931627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.
    Sarmiento JG; Janis RA; Katz AM; Triggle DJ
    Biochem Pharmacol; 1984 Oct; 33(20):3119-23. PubMed ID: 6487362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
    Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
    Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry.
    Batra S
    Br J Pharmacol; 1985 Aug; 85(4):767-74. PubMed ID: 2412621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclandelate as a calcium modulating agent in rat cerebral cortex.
    Bast A; Leurs R; Timmerman H
    Drugs; 1987; 33 Suppl 2():67-74. PubMed ID: 3040372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyamines allosterically modulate [3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain.
    Schoemaker H
    Eur J Pharmacol; 1992 Feb; 225(2):167-9. PubMed ID: 1312941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    Schoemaker H; Langer SZ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.